Interleukin-6 (IL-6) Receptor Antagonist Protects Against Rheumatoid Arthritis

BACKGROUND: The aim of this study was to investigate the protective effect of interleukin-6 (IL-6) receptor antagonist tocilizumab (TCZ) on rheumatoid arthritis (RA) and its related mechanism. MATERIAL/METHODS: Thirty RA patients receiving long-term methotrexate therapy at moderate and severe active...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Songsong, Wu, Zhenzhou, Li, Ling, Liu, Xuehua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920098/
https://www.ncbi.nlm.nih.gov/pubmed/27322646
http://dx.doi.org/10.12659/MSM.896355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920098/
https://www.ncbi.nlm.nih.gov/pubmed/27322646
http://dx.doi.org/10.12659/MSM.896355

Ejemplares similares